(Reuters) -AstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the drugmaker, ending a row about shortages that had weighed on the company and the region's vaccination campaign.
The dispute plunged the European Union into crisis earlier this year as states, under pressure to speed up vaccinations, scrambled for shots. It also caused a public relations crisis for AstraZeneca, which is led by Frenchman Pascal Soriot.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
